Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1993 1
1994 2
1996 2
1997 5
1998 1
1999 4
2000 2
2001 2
2002 2
2003 1
2005 3
2006 1
2008 2
2009 6
2010 3
2012 1
2013 1
2014 1
2016 2
2017 1
2018 5
2019 1
2020 2
2022 1
2023 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.
Nappi A, Berretta M, Romano C, Tafuto S, Cassata A, Casaretti R, Silvestro L, Divitiis C, Alessandrini L, Fiorica F, Ottaiano A, Nasti G. Nappi A, et al. Among authors: casaretti r. Curr Cancer Drug Targets. 2018;18(5):421-429. doi: 10.2174/1568009617666170209095143. Curr Cancer Drug Targets. 2018. PMID: 28183254 Review.
Role of shrinkage in esophageal-gastric junction cancer.
Leongito M, Palaia R, Casaretti R, Tatangelo F, Foschini F, Di Mauro A, Belli A, Albino V. Leongito M, et al. Among authors: casaretti r. Clin Case Rep. 2023 Jun 12;11(6):e6982. doi: 10.1002/ccr3.6982. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37312927 Free PMC article.
First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.
Ottaiano A, De Stefano A, Capozzi M, Nappi A, De Divitiis C, Romano C, Silvestro L, Cassata A, Casaretti R, Tafuto S, Caraglia M, Berretta M, Nasti G, Avallone A. Ottaiano A, et al. Among authors: casaretti r. Front Pharmacol. 2018 May 3;9:441. doi: 10.3389/fphar.2018.00441. eCollection 2018. Front Pharmacol. 2018. PMID: 29773991 Free PMC article. Review.
Optimizing the management of metastatic colorectal cancer.
Comella P, Casaretti R, Avallone A, Franco L. Comella P, et al. Among authors: casaretti r. Crit Rev Oncol Hematol. 2010 Jul;75(1):15-26. doi: 10.1016/j.critrevonc.2009.09.008. Epub 2009 Oct 17. Crit Rev Oncol Hematol. 2010. PMID: 19837601 Review.
Emerging role of capecitabine in gastric cancer.
Comella P, Franco L, Casaretti R, de Portu S, Menditto E. Comella P, et al. Among authors: casaretti r. Pharmacotherapy. 2009 Mar;29(3):318-30. doi: 10.1592/phco.29.3.318. Pharmacotherapy. 2009. PMID: 19249950 Review.
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.
Cardone C, De Stefano A, Rosati G, Cassata A, Silvestro L, Borrelli M, Di Gennaro E, Romano C, Nappi A, Zanaletti N, Foschini F, Casaretti R, Tatangelo F, Lastoria S, Raddi M, Bilancia D, Granata V, Setola S, Petrillo A, Vitagliano C, Gargiulo P, Arenare L, Febbraro A, Martinelli E, Ciardiello F, Delrio P, Budillon A, Piccirillo MC, Avallone A. Cardone C, et al. Among authors: casaretti r. ESMO Open. 2023 Feb;8(1):100748. doi: 10.1016/j.esmoop.2022.100748. Epub 2023 Jan 3. ESMO Open. 2023. PMID: 36603521 Free PMC article. Clinical Trial.
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Rosati G, Cella CA, Cavanna L, Codecà C, Prisciandaro M, Mosconi S, Luchena G, Silvestris N, Bernardini I, Casaretti R, Zoratto F, Amoroso D, Ciarlo A, Barni S, Cascinu S, Davite C, Di Sanzo A, Casolaro A, Bilancia D, Labianca R. Rosati G, et al. Among authors: casaretti r. Gastric Cancer. 2022 Jul;25(4):783-793. doi: 10.1007/s10120-022-01292-y. Epub 2022 Mar 30. Gastric Cancer. 2022. PMID: 35352176 Clinical Trial.
54 results